FDA recall D-1156-2022

Teva Pharmaceuticals USA Inc · Class II · drug

Product

Tretinoin Capsules, 10 mg, Rx Only, 100 capsules per bottle, Teva Pharmaceuticals USA Inc., North Wales, PA, 19454, NDC 0555-0808-02.

Reason for recall

Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.

Distribution

Nationwide in the U.S.

Key facts

Status
Terminated
Initiation date
2022-06-14
Report date
2022-06-29
Termination date
2023-04-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1156-2022